JP2025503214A5 - - Google Patents

Info

Publication number
JP2025503214A5
JP2025503214A5 JP2024544709A JP2024544709A JP2025503214A5 JP 2025503214 A5 JP2025503214 A5 JP 2025503214A5 JP 2024544709 A JP2024544709 A JP 2024544709A JP 2024544709 A JP2024544709 A JP 2024544709A JP 2025503214 A5 JP2025503214 A5 JP 2025503214A5
Authority
JP
Japan
Application number
JP2024544709A
Other languages
Japanese (ja)
Other versions
JP2025503214A (ja
JPWO2023143365A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2023/073130 external-priority patent/WO2023143365A1/zh
Publication of JP2025503214A publication Critical patent/JP2025503214A/ja
Publication of JP2025503214A5 publication Critical patent/JP2025503214A5/ja
Publication of JPWO2023143365A5 publication Critical patent/JPWO2023143365A5/ja
Pending legal-status Critical Current

Links

JP2024544709A 2022-01-28 2023-01-19 Her3抗体-薬物結合体及びその使用 Pending JP2025503214A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202210107800.8 2022-01-28
CN202210107800 2022-01-28
CN202310015113 2023-01-05
CN202310015113.8 2023-01-05
PCT/CN2023/073130 WO2023143365A1 (zh) 2022-01-28 2023-01-19 Her3抗体药物偶联物及其用途

Publications (3)

Publication Number Publication Date
JP2025503214A JP2025503214A (ja) 2025-01-30
JP2025503214A5 true JP2025503214A5 (https=) 2026-01-26
JPWO2023143365A5 JPWO2023143365A5 (https=) 2026-01-26

Family

ID=87470787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024544709A Pending JP2025503214A (ja) 2022-01-28 2023-01-19 Her3抗体-薬物結合体及びその使用

Country Status (10)

Country Link
US (1) US20250295802A1 (https=)
EP (1) EP4470570A1 (https=)
JP (1) JP2025503214A (https=)
KR (1) KR20240157659A (https=)
CN (1) CN118434453A (https=)
AU (1) AU2023213783A1 (https=)
IL (1) IL314567A (https=)
MX (1) MX2024009159A (https=)
TW (1) TW202341984A (https=)
WO (1) WO2023143365A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20252282A1 (es) * 2022-10-09 2025-09-18 Lanova Medicines Ltd Compuestos, composiciones y metodos
IL320634A (en) * 2022-11-04 2025-07-01 Alx Oncology Inc EXATECAN derivatives and antibody-drug conjugates
EP4692091A1 (en) * 2023-04-07 2026-02-11 Changchun Genescience Pharmaceutical Co., Ltd. Camptothecin derivative, and pharmaceutical composition, preparation method therefor and use thereof
WO2024248123A1 (ja) 2023-06-02 2024-12-05 第一三共株式会社 抗her3抗体-薬物コンジュゲートとrasg12c阻害剤の組み合わせ
WO2025031286A1 (zh) * 2023-08-04 2025-02-13 映恩生物制药(苏州)有限公司 抗体药物偶联物的识别抗体及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
AR056857A1 (es) 2005-12-30 2007-10-24 U3 Pharma Ag Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
KR102399277B1 (ko) * 2014-04-10 2022-05-18 다이이찌 산쿄 가부시키가이샤 항her3 항체-약물 콘주게이트
KR20210062005A (ko) * 2018-09-20 2021-05-28 다이이찌 산쿄 가부시키가이샤 항 her3 항체-약물 콘쥬게이트 투여에 의한 her3 변이암의 치료
WO2020063676A1 (zh) * 2018-09-26 2020-04-02 江苏恒瑞医药股份有限公司 依喜替康类似物的配体-药物偶联物及其制备方法和应用
MX2023003778A (es) * 2020-09-30 2023-04-26 Duality Biologics Suzhou Co Ltd Compuesto antitumoral, metodo de preparacion y uso del mismo.
AU2022293634A1 (en) * 2021-06-15 2024-01-18 Beijing Sinotau Bio-Pharmaceuticals Technology Co., Ltd. Anti-her3 antibody, antibody drug conjugate containing the same, and use thereof

Similar Documents

Publication Publication Date Title
JP2025503214A5 (https=)
CL2026000084A1 (es) Composiciones herbicidas que comprenden malonamidas y protectores para el control de malezas selectivo en cultivos
JP2024523885A5 (https=)
CL2026000145A1 (es) Un colector deslizable de corriente y método para contactar el riel conductor
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307049661S (https=)
BY13137U (https=)
CN307049165S (https=)
CN307048993S (https=)
BY13169U (https=)
CN307047666S (https=)
CN307047012S (https=)
CN307045902S (https=)
BY13145U (https=)
CN307045658S (https=)
BY13144U (https=)
CN307045425S (https=)
CN307044920S (https=)